drugset / Trial / NCT00929409
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
Phase 2/3
Terminated
30 enrolled
Norwegian University of Science and Technology
St. Olavs Hospital · collabSykehuset Buskerud HF · collabSykehuset Innlandet HF · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
200 patients with post partum anemia will be randomised to receive either intravenous iron (intervention group) or peroral iron (control group). The hypothesis is that intravenous iron supplementation is superior to standard peroral iron.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | — | Intravenous |
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | 100 mg | Oral |